Universal Orthodontic Lab Appoints Dr. Ryo Hamanaka as Chief Clinical Officer to Advance Clinical Innovation and Next-Generation Orthodontic Solutions Universal Orthodontic Lab, a leading orthodontic laboratory headquartered in Norwalk, California, has announced the appointment of Dr. Ryo Hamanaka as Chief…
Studion Promotes Brian Harrington to General Manager of Life Sciences Business to Drive Growth of eClinical Services Studion, a technology services company specializing in the design, development, and delivery of digital experiences for the Learning and Life Sciences sectors, has…
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate Bausch + Lomb Corporation a leading global eye health company dedicated to helping people see better to live better, today announced topline results from its Phase 2 study evaluating…
Immunocine Cancer Center Appoints Vita S. Salsman as Executive Director to Advance Personalized Cancer Immunotherapy Immunocine Cancer Center has announced the appointment of Vita S. Salsman as its new Executive Director, a leadership move that reflects the organization’s continued commitment…
Paradromics Strengthens Clinical Leadership with Appointment of Dr. William J. Marks Jr. as Chief Clinical Officer Paradromics Inc., a clinical-stage neurotechnology company developing high-bandwidth brain-computer interface (BCI) systems, has announced the appointment of renowned neurologist and clinical scientist William J.…
LTZ Therapeutics Receives FDA Clearance to Begin Clinical Evaluation of LTZ-232 for Advanced Metastatic Colorectal Cancer and Other Solid Tumors LTZ Therapeutics, a clinical-stage biotechnology company focused on developing next-generation cancer immunotherapies, has announced that the U.S. Food and Drug…
Uniquity Bio Strengthens Executive Leadership with Appointment of Matthew Hartzell as Chief Financial Officer Uniquity Bio, a clinical-stage biotechnology company dedicated to developing innovative therapies for immune-mediated and inflammatory diseases, has announced the appointment of Matthew Hartzell as its new…
Genmab Wins European Commission Approval for TEPKINLY® Combination Genmab A/S has announced that the European Commission (EC) has granted marketing authorization for TEPKINLY® (epcoritamab) in combination with lenalidomide and rituximab (R2) for the treatment of adult patients with relapsed or…
PharmaEssentia Receives Health Canada Approval for BESREMi® to Treat Adults with Polycythemia Vera PharmaEssentia Corporation, a Taiwan-based global biopharmaceutical company specializing in the development of innovative biologic therapies for hematology and oncology, has announced that its wholly owned subsidiary, FORUS…
Novartis Secures EU Approval for Itvisma® in SMA Novartis has announced that the European Commission (EC) has granted approval for Itvisma® (onasemnogene abeparvovec) for the treatment of children aged two years and older, adolescents, and adults living with 5q spinal…
Visby Medical Receives FDA Clearance for First At-Home Multi-Viral PCR Test for COVID-19 and Influenza Visby Medical, a company focused on developing rapid molecular diagnostics for use at home, has announced that the U.S. Food and Drug Administration (FDA) has…
PeptiDream Strengthens Executive Leadership Team with Three New Executive Vice Presidents to Accelerate Global Growth PeptiDream Inc., a publicly traded biopharmaceutical company headquartered in Kawasaki, Japan, has announced the appointment of three new Executive Vice Presidents as part of its…